Dr. Reddy's Laboratories, Inc. recalls Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limite…
- Recall date
- March 6, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1001-2019
- FDA classification
- Class II
- Brand / firm
- Dr. Reddy's Laboratories, Inc.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, Andhra Pradesh, INDIA, NDC 43598-259-40.
Get recall alerts
Free email alert whenever Dr. Reddy's Laboratories, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Dr. Reddy's Laboratories, Inc.